AI in Healthcare

The latest on artificial intelligence transforming medicine

News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.

Filtered by: digital pathologyClear filter
researchNature

Prostate Pathology Study Spotlights a Hidden Weakness in Diagnostic AI

A Nature paper on prostate digital pathology examines how tissue detection affects diagnostic AI algorithms. The work points to a subtle but important failure mode: if the model cannot reliably identify what tissue to analyze, downstream diagnosis can be compromised.

prostate cancerdigital pathologyNaturediagnostic AI
research

Nature Study Probes a Key Weakness in AI Pathology for Prostate Cancer

A Nature study examines how tissue detection affects diagnostic AI algorithms in prostate digital pathology. The paper is important because it moves the discussion away from headline-grabbing accuracy claims and toward a core technical issue: what happens when a model cannot reliably identify the tissue it is supposed to analyze. That kind of failure can quietly undermine otherwise impressive pathology AI systems.

Nature
AIdigital pathologyprostate cancer
regulation

AI Is Getting Better at Breast Cancer Diagnosis, and Pathology Is Catching Up

The FDA has cleared an AI digital pathology risk stratification tool for breast cancer, marking another regulatory milestone for AI in oncology. The clearance suggests pathology is moving from proof-of-concept toward clinically governed deployment.

Imaging Technology News
FDAdigital pathologybreast cancer
research

AI in pathology is becoming the new center of gravity for breast cancer detection and prognosis

Devdiscourse reports that AI-driven pathology is reshaping how breast cancer is detected and prognosticated. The trend suggests pathology may become one of the most consequential, and least flashy, areas of medical AI.

Devdiscourse
pathologybreast cancerprognosis
technology

AI in Pathology Is Becoming the Quiet Engine of Oncology

Medscape’s look at AI in oncology pathology highlights a field that may be less visible than radiology, but just as important. Pathology sits at the center of diagnosis, grading, and treatment selection, making it a natural place for AI to influence care. The real opportunity is not just automation, but better prioritization and more consistent interpretation.

Medscape
pathologyoncologyAI
clinical

Pathology AI Pushes Into Chemotherapy Decision Support in Breast Cancer

A new AI tool that evaluates pathology slides to guide chemotherapy decisions points to the next phase of digital pathology: moving from detection and classification into treatment selection. That shift could make pathology AI more clinically influential, but also subject it to a much higher evidentiary bar.

Inside Precision Medicine
digital pathologybreast cancerchemotherapy
research

Digital pathology AI review highlights a field advancing faster than its evidence standards

A medRxiv review of AI devices for image analysis in digital pathology points to rapid technical progress in one of medicine’s most data-rich specialties. It also reinforces a familiar concern: deployment pressure is rising faster than consensus on validation, comparability, and real-world utility.

medRxiv
digital pathologyAI devicesimage analysis
industry

Startup funding for AI lymphoma diagnostics signals pathology’s next commercialization wave

Spotlight Pathology’s £1.4 million raise for an AI lymphoma diagnostic is a small financing round with larger strategic meaning. It suggests that pathology AI is continuing to specialize into narrower, disease-specific products that may prove easier to validate and commercialize than broad platform claims.

eurekamagazine.co.uk
pathology AIlymphomastartup funding
industry

Lymphoma Diagnostic Startup’s New Funding Shows AI Pathology Is Moving Past the Pilot Phase

A UK AI lymphoma diagnostic company has secured £1.4 million for commercial rollout, suggesting investor confidence in narrower, clinically targeted pathology tools. The story is less about the funding size and more about where capital is flowing: deployable products aimed at real diagnostic bottlenecks.

The Engineer
lymphomapathology AIfunding

How this works

Discover

An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.

Structure

The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.

Publish

Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.